Synergetics Investor Takes Aim At Valeant Deal
A Synergetics investor has launched a putative class action in Delaware Chancery Court, alleging that Valeant's acquisition of the medical device company was the result of a "tainted and co-opted" sales...To view the full article, register now.
Already a subscriber? Click here to view full article